alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 7


<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                        DEC-31-1999
<PERIOD-START>                           JAN-01-1999
<PERIOD-END>                             DEC-31-1999
<DEBT-HELD-FOR-SALE>                      30,896,604
<DEBT-CARRYING-VALUE>                              0
<DEBT-MARKET-VALUE>                                0
<EQUITIES>                                 8,384,653
<MORTGAGE>                                         0
<REAL-ESTATE>                                      0
<TOTAL-INVEST>                            39,281,257
<CASH>                                     5,127,555
<RECOVER-REINSURE>                                 0
<DEFERRED-ACQUISITION>                       871,362
<TOTAL-ASSETS>                            47,303,161
<POLICY-LOSSES>                           25,037,009
<UNEARNED-PREMIUMS>                        3,057,408
<POLICY-OTHER>                                     0
<POLICY-HOLDER-FUNDS>                              0
<NOTES-PAYABLE>                                    0
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<COMMON>                                     331,731
<OTHER-SE>                                18,609,813
<TOTAL-LIABILITY-AND-EQUITY>              47,303,161
<PREMIUMS>                                 6,388,323
<INVESTMENT-INCOME>                        2,163,278
<INVESTMENT-GAINS>                           532,854
<OTHER-INCOME>                                     0
<BENEFITS>                                 6,744,893
<UNDERWRITING-AMORTIZATION>                1,770,098
<UNDERWRITING-OTHER>                       1,097,171
<INCOME-PRETAX>                            (527,707)
<INCOME-TAX>                               (676,317)
<INCOME-CONTINUING>                                0
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                    234,000
<NET-INCOME>                             (1,438,024)
<EPS-BASIC>                                   (4.33)
<EPS-DILUTED>                                 (4.33)
<RESERVE-OPEN>                            20,842,402
<PROVISION-CURRENT>                        9,277,893
<PROVISION-PRIOR>                        (2,533,000)
<PAYMENTS-CURRENT>                         (147,476)
<PAYMENTS-PRIOR>                         (3,077,013)
<RESERVE-CLOSE>                           24,362,806
<CUMULATIVE-DEFICIENCY>                            0



</TABLE>
<PAGE>   1
                                                                   EXHIBIT 10.29

                                                  [BAR CODE - US005895354A]

UNITED STATES PATENT  [19]               [11]     PATENT NUMBER:       5,895,354
SIMMONS                                  [45]     DATE OF PATENT:  APR. 20, 1999
--------------------------------------------------------------------------------


[54]     INTEGRATED MEDICAL DIAGNOSTIC CENTER

[76]     Inventor:  PAUL L. SIMMONS, 8825 Laurel Dr.,
                    Pinellas Park, Fla. 33782

[21]     Appl. No.: 08/882,201

[22]     Filed:     JUN. 25, 1997

                          RELATED U.S. APPLICATION DATA

[60]     Provisional application No. 60/020,625, Jun. 26, 1996.

[51]     INT. *CL(6)..................................................A61B 5/00
[52]     U.S. CL......................................600/301; 600/300; 600/494;
                                                                        128/903
[58]     FIELD OF SEARCH .............................128/903; 600/300, 600/301,
                                               494; 5/600, 136, 159.1, 160, 161

[56]                          REFERENCES CITED

                              U.S. PATENT DOCUMENTS

         4,998,534   3/1991  Claxton, III et al. ......................  600/494
         5,441,047   8/1995  David et al.  ............................  600/301
         5,621,930   4/1997  Reppas et al. ............................    5/136
         5,701,904  12/1997  Simmons et al. ...........................  600/301

Primary Examiner         -- Robert L. Nasser
Assistant Examiner       -- Michael Astorino
Attorney, Agent, or Firm -- A. W. Fisher, III

[57]                               ABSTRACT

An integrated medical diagnostic center configured to provide emergency
communications, immediate measurement of various physiological conditions and
provision for administration of emergency treatment, the integrated medical
diagnostic center comprising a cabinet including a plurality of compartments to
house an emergency communications device, a plurality of physiological
diagnostic devices, at least one patient support movable between a stored
position and an operative position and at least one emergency treatment device.

                          29 CLAIMS, 7 DRAWING SHEETS


                                   [PICTURE]
#### R. F. SIMONTON, Adm’r. &c., *v.*GEORGE W. CHIPLEY.

The Supreme Court has appellate jurisdiction over questions *of law*only, and so cannot review the exercise of a discretionary power over matters *of*fact:

*Therefore,*it cannot review a question as to the propriety of an order striking out a judgment for irregularity; turning, in some degree, upon whether it were given without a verdict, and in the absence of the defendant and his attorney.

Where an order of amendment given in the County Court, had been appealed from, and, pending the appeal, that Court had been abolished,' and its records transferred to the Superior Court; *Held,*that upon an affirmation of the order, the amendment should be made in the latter Court.

*[BriU*v. *Patterson,*10 Ire. 390, and *Bagley*v. *Wood,*12 Id. 90j cited and approved.)

Motior to set aside a judgment, heard by *Buxton, J.,*at July Special Term 1869 of Iredell Court.

The question had been brought by appeal from the County Court of that county, in which at August Term 1867, an order had been made, upon the motion of the defendant, to-set aside a judgment in *debt,*taken by the plaintiff’s intestate against him, at August Term 1861.

In support of his motion the defendant had introduced' *153evidence that upon the reton of the writ in the action (May-Term 1861) he had appeared, and pleaded General Issue, Payment-and-set-off, and Statute-of-Limitations; and that at the next term, in his absence, and the absence of his attorney, an entry of “ Judg’t ” had been made on the docket,— upon which, execution had been issued for $78893 and costs, &c.; that the affiant was not informed of the rendition of the judgment for a long time after, &c.

Prom the order to vacate such judgment and amend the record *mine pro tunc,*&c., the plaintiff appealed to the Superior Court.

His Honor affirmed that judgment, and the plaintiff appealed again.

*W.*P. *Caldwell*for the appellant.

*Clement 8c Boyden and Bailey, contra.*

Dick, J.

This court cannot review the judgment in the court below, as it was rendered in the exercise of a discretionary power in matters of fact.

The appellate jurisdiction of this court extends only to the correction of errors in law. It cannot hear evidence in a cause, and of course cannot properly determine questions, depending upon facts.

This doctrine has been so fully discussed, and is so well settled, that it is unnecessary for us to consider it further: *Britt*v. *Patterson,*10 Ire. 390; *Bagley*v. *Wood,*12 Id. 90.

We concur in the ruling of his Honor in the court below, and the judgment must be affirmed.

As the records of the late County Court are now under the control of the Superior Court, that coiut must make the amendment ordered by the County Court, and the parties can proceed as they may be advised.

Let this be certified.

Per Curiam:. Judgment affirmed.
EXHIBIT 32.1



CERTIFICATION OF CEO AND CFO PURSUANT TO

18 U.S.C. § 1350

AS ADOPTED PURSUANT TO

§ 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Form 10-Q of Security Bank Corporation (the Company) for the period ended March 31, 2005 as filed with the Securities and Exchange Commission on
the Date hereof (the Report), H. Averett Walker, Chief Executive Officer of the Company, and James R. McLemore, Jr., Chief Financial and Accounting Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant
to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                                        |  |             
|--------------------------------------------------------------------------------------- |  | ------------
|Date:                                                                                   |  | May 10, 2005
|/s/ H. Averett
WalkerH. Averett Walker Chief Executive Officer                         
|                                                                                        | 
|Date:                                                                                   |  | May 10, 2005
|/s/ James R.
McLemore, Jr.James R. McLemore, Jr. Chief Financial and Accounting Officer



This certification accompanies this
Report pursuant to § 906 of the Sarbanes-Oxley Act 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.



41
### STN Easy: Easy Search Main Page

Display Page

Easy Search Advanced Search CAS Number Search Patent Lookup Defined Searches

Review Saved Items

+ Help

Session Cost

Price List

Preferences

Search History

+ Cust. Support

Comments 

# Log Off Display Page

Display without Links 

## | Return to Results


# Display from REGISTRY

ANSWER 1 © 2011 ACS on STN

CAS Registry Number

Chemical Name

Molecular Formula

Search for information related to CAS RN in these categories: Agriculture [$2.00] Biotechnology [$2.00]

Chemical Catalogs [$2.00]

Chemical Substances [$2.00] Chemistry References [$2.00]

Restricted to: NO RESTRICTIONS

-------------- Preparation Industrial Manufacture Synthetic Preparation Formation, Nonpreparative Purification

-------------- General Science [$2.00]

Life Sciences [$2.00]

Patents [$2.00]
Patents, Full Text [$2.00]
Patents, National [$2.00] Pharmacology [$2.00] Physics [$2.00] Regulated Chemical Lists [$2.00] Toxicology [$2.00]

with

### STN Easy: Easy Search Main Page
Order filed July 2, 2015

.

In The



## Fourteenth Court of Appeals

____________

NO. 14

- 15

- 00420

- CV

___________ UNIVERSAL MRI AND DI AGNOSTICS INC. , Appellant

V.

MEDICAL LIEN MANAGEM ENT INC. D/B/A BRID GEWELL , Appellee

On Appeal from the 295th District Court

Harris County, Texas

Trial Court Cause No. 321010295

O R D E R

No reporter’s record has been filed in this case. The official court reporter

for the 295th District Court informed this court that appellant had not made

arrangements for p ayment for the reporter’s record. On May 14, 2015 , the clerk of

this court notified appellant that we would consider and decide those issues that do

not require a reporter = s record unless appellant, within 15 days of notice, provided

this court with proof of payment for the record. See T ex. R. App

. P. 37.3(c).

Appellant filed no reply.Accordingly, we order appellant to file a brief in this appeal within thirty

days of the date of this order. If appellant fails to comply with this order, the court

wi ll dismiss the appeal for want of prosecution. See Tex. R. App. P. 42.3(b).

PER CURIAM
Fourth Court of Appeals

San Antonio, Texas

October 27, 2020

No. 04-20-00202-CV

MUSCULOSKELETAL IMAGING CONSULTANTS, LLC,

Appellant

v.

JAR ENTERPRISES, INC. d/b/a Premier Medical Imaging,

Appellee

From the 166th Judicial District Court, Bexar County, Texas

Trial Court No. 2019-CI-12957

Honorable Cynthia Marie Chapa, Judge Presiding

O R D E R

The Appellee's Motion for Extension of Time to File Brief is hereby GRANTED. The 

appellee's brief is due October 26, 2020.

_________________________________

Liza A. Rodriguez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 27th day of October, 2020.

___________________________________

MICHAEL A. CRUZ, 

Clerk of Court
Exhibit 31.2


          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
            PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Patricia Giuliani-Rheaume, certify that

1. I have reviewed  this  quarterly  report on Form 10-QSB of  clickNsettle.com,
Inc. (the "Registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on  my  knowledge,  the  financial  statements  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods presented in this report;

4.  The  Registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

a) Designed such disclosure  controls and procedures,  or caused such disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  Registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this report is being prepared;

b) Evaluated  the  effectiveness  of the  Registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the Registrant's internal control over
financial  reporting that occurred during the Registrant's  first fiscal quarter
that has materially affected,  or is reasonably likely to materially affect, the
Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
Registrant's  auditors  and the audit  committee  of the  Registrant's  board of
directors (or persons performing the equivalent functions):

      (a)   All significant  deficiencies in the design or operation of internal
            control over  financial  reporting  which are  reasonably  likely to
            adversely  affect  the  Registrant's  ability  to  record,  process,
            summarize and report financial information; and

      (b)   Any fraud,  whether or not  material,  that  involves  management or
            other  employees  who have a  significant  role in the  Registrant's
            internal control over financial reporting.

Date:  November 9, 2006

/s/ Patricia Giuliani-Rheaume
-----------------------------------------------
Patricia Giuliani-Rheaume - Vice President,
Chief Financial Officer and Treasurer
# Euroopa Liidu C 146A/26.

| | ISSN 1977-0898 |
| --- | --- |
| Euroopa Liidu
  Teataja | C 146A |
| | |
| Eestikeelne väljaanne | Teave ja teatised | 59. köide26. aprill 2016 |

ISSN 1977-0898

Euroopa Liidu

Teataja

C 146A

Eestikeelne väljaanne

Teave ja teatised

59. köide26. aprill 2016

---

| Teatis nr | Sisukord | Lehekülg |
| --- | --- | --- |
| | V   Teated |
| | HALDUSMENETLUSED |
| | Kontrollikoda |
| 2016/C 146A/01 | Reservnimekiri (pingerida) — ECA/2015/JUR – 2 juristi ametikohta (palgaastmed AD 8 — AD 9) — Õigustalitus – presidendi direktoraat | 1 |

Teatis nr

Sisukord

Lehekülg

V   Teated

HALDUSMENETLUSED

Kontrollikoda

2016/C 146A/01

Reservnimekiri (pingerida) — ECA/2015/JUR – 2 juristi ametikohta (palgaastmed AD 8 — AD 9) — Õigustalitus – presidendi direktoraat

1

---

| ET | |
| --- | --- |

ET

---

V Teated

HALDUSMENETLUSED

Kontrollikoda

| 26.4.2016 | ET | Euroopa Liidu Teataja | CA 146/1 |
| --- | --- | --- | --- |

26.4.2016

ET

Euroopa Liidu Teataja

CA 146/1

---

RESERVNIMEKIRI

(pingerida)

ECA/2015/JUR – 2 juristi ametikohta (palgaastmed AD 8 — AD 9)

Õigustalitus – presidendi direktoraat

(2016/C 146 A/01)

Georgios PRANTZOS

Johanne VERMER

Eléonore VON BARDELEBEN

Nunzio BAMBARA

Jan KLEIN

Vassilis KARANTOUNIAS

---
### THE THIRTEENTH COURT OF APPEALS

13

- 20

- 00003

- CR

Norma DeLeon
v. The State of Texas

On Appeal from the 117th District Court of Nueces County , Texas Trial Cause No. 19FC

- 0474

- B

JUDGMENT
THE THIRTEENTH COURT OF APPEALS, having considered this cause on
appeal, concludes the appeal should be dismissed. The Court orders the appeal

DISMISSED in accordance with its opinion

. We further order this decision certified below for observance.
September 24, 2020
<Page>

                                                                     EXHIBIT 4.1

                            Certificate of Amendment
                                     to the
                  Second Restated Certificate of Incorporation
                                       of
                         Triangle Pharmaceuticals, Inc.

         Triangle Pharmaceuticals, Inc., a corporation organized and existing
under the laws of the State of Delaware, hereby certifies as follows:

         1. The name of the corporation is Triangle Pharmaceuticals, Inc.
The corporation's Second Restated Certificate of Incorporation was filed with
the Secretary of State of the State of Delaware on October 30, 1996 and was
amended pursuant to two Certificates of Designation filed on December 23, 1998
and February 8, 1999,respectively.

         2. Pursuant to Section 242 of the General Corporation Law of the State
of Delaware, this Certificate of Amendment was adopted by the corporation's
Board of Directors and stockholders.

         3. The Second Restated Certificate of Incorporation is hereby amended
as follows: Paragraph (A) of Article IV is deleted and replaced with the
following:

         "(A) CLASSES OF STOCK. This corporation is authorized to issue two
classes of stock, denominated Common Stock and Preferred Stock. The Common Stock
shall have a par value of $0.001 per share and the Preferred Stock shall have a
par value of $0.001 per share. The total number of shares of Common Stock which
the corporation is authorized to issue is one hundred seventy-five million
(175,000,000), and the total number of shares of Preferred Stock which the
corporation is authorized to issue is ten million (10,000,000), which shares of
Preferred Stock shall be undesignated as to series."

         IN WITNESS WHEREOF, this Certificate of Amendment has been signed under
the seal of the corporation as of the 10th day of October, 2001.

                             TRIANGLE PHARMACEUTICALS, INC.
                             a Delaware corporation

                             By:   /s/ Chris A. Rallis
                                 --------------------------------------------
                                   Chris A. Rallis
                                   President and Chief Operating Officer

                             ATTEST:


                                   /s/ R. Andrew Finkle
                                   ------------------------------------------
                                   R. Andrew Finkle
                                   Executive VP, General Counsel & Secretary
II

Calendar No. 67

106TH CONGRESS

1ST SESSION S. 361

[Report No. 106–29]

To direct the Secretary of the Interior to transfer to John R. and Margaret

J. Lowe of Big Horn County, Wyoming, certain land so as to correct

an error in the patent issued to their predecessors in interest.

IN THE SENATE OF THE UNITED STATES

FEBRUARY 3, 1999

Mr. ENZI (for himself and Mr. THOMAS) introduced the following bill; which

was read twice and referred to the Committee on Energy and Natural

Resources

MARCH 22, 1999

Reported by Mr. MURKOWSKI, without amendment

A BILL

To direct the Secretary of the Interior to transfer to John

R. and Margaret J. Lowe of Big Horn County, Wyoming, certain land so as to correct an error in the

patent issued to their predecessors in interest.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

S 361 RS

1 SECTION 1. TRANSFER OF LOWE FAMILY PROPERTY.

2 (a) CONVEYANCE.—Subject to valid existing rights,

3 the Secretary of the Interior is directed to issue, without

4 consideration, a quitclaim deed to John R. and Margaret

5 J. Lowe of Big Horn County, Wyoming, to the land de6 scribed in subsection (b): Provided, That all minerals un7 derlying such land are hereby reserved to the United

8 States.

9 (b) LAND DESCRIPTION.—The land referred to in

10 subsection (a) is the approximately 40-acre parcel located

in the SW1⁄4SE1 11 ⁄4 of Section 11, Township 51 North,

12 Range 96 West, 6th Principal Meridian, Wyoming.

Calendar No. 67

106TH CONGRESS

1ST SESSION S. 361

[Report No. 106–29]

A BILL

To direct the Secretary of the Interior to transfer

cessors in interest.an error in the patent issued to their predeCounty, Wyoming, certain land so as to correctto John R. and Margaret J. Lowe of Big Horn

MARCH 22, 1999

Reported without amendment